Assessing exposure risks for aquatic organisms posed by Tamiflu use under seasonal influenza and pandemic conditions

Environmental Pollution

Volumn 184, Issue , 2014, Pages 377-384

  Chen, Wei Yu ^a   Lin, Chia Jung ^b   Liao, Chung Min ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Ecotoxicology; Environmental risk assessment; Epidemiology; Influenza; Oseltamivir; Tamiflu

Indexed keywords

ECO-TOXICOLOGY; ENVIRONMENTAL RISK ASSESSMENT; INFLUENZA; OSELTAMIVIR; TAMIFLU;

AQUATIC ORGANISMS; BIOHAZARDS; ENVIRONMENTAL IMPACT; EPIDEMIOLOGY;

RISK ASSESSMENT;

OSELTAMIVIR;

ALGA; AQUATIC ORGANISM; BIOASSAY; CONCENTRATION (COMPOSITION); CYPRINID; DRUG; ECOTOXICOLOGY; ENVIRONMENTAL RISK; EPIDEMIOLOGY; INFLUENZA; POLLUTION EXPOSURE; RISK ASSESSMENT; ZOOPLANKTON;

2009 H1N1 INFLUENZA; ALGA; ALGAL GROWTH; AQUATIC ENVIRONMENT; AQUATIC SPECIES; ARTICLE; BIOASSAY; CONCENTRATION (PARAMETERS); DAPHNIA; DRUG ELIMINATION; DRUG UPTAKE; DRUG USE; ECOTOXICOLOGY; ENVIRONMENTAL EXPOSURE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; NONHUMAN; PANDEMIC INFLUENZA; PROBABILITY; RISK ASSESSMENT; SEASONAL INFLUENZA; TAIWAN; WATER ANALYSIS; WATER CONTAMINATION; ZEBRA FISH;

TAIWAN;

ECOTOXICOLOGY; ENVIRONMENTAL RISK ASSESSMENT; EPIDEMIOLOGY; INFLUENZA; OSELTAMIVIR; TAMIFLU;

ANIMALS; ANTIVIRAL AGENTS; AQUATIC ORGANISMS; DAPHNIA; ENVIRONMENTAL EXPOSURE; MODELS, CHEMICAL; OSELTAMIVIR; PANDEMICS; RISK ASSESSMENT; SEASONS; TAIWAN; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION, CHEMICAL;

EID: 84885166085     PISSN: 02697491     EISSN: 18736424     Source Type: Journal    
DOI: 10.1016/j.envpol.2013.09.019     Document Type: Article

References (40)

1. C. Accinelli, A.B. Caracciolo, and P. Grenni Degradation of the antiviral drug oseltamivir carboxylate in surface water samples Int. J. Environ. Anal. Chem. 87 2007 579 587 (Pubitemid 46868183)
2. R.M. Anderson, and R.M. May Infectious Diseases of Humans: Dynamics and Control 1991 Oxford University Press New York
3. T. Azuma, N. Nakada, N. Yanashita, and H. Tanaka Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreaks Environ. Sci. Technol. 46 2012 12873 12881
4. S.C. Chen, and C.M. Liao Probabilistic indoor transmission modeling for influenza (sub)type viruses J. Infect. 60 2010 26 35
5. B. Davies Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations J. Antimicrob. Chemother. 65 Suppl. 2 2010 ii5 10
6. EMEA Guidance on Environmental Risk Assessment of Medicinal Products for Human Use CPMP/SWP/4447/00 2006 EMEA London, UK URL: http://www.ema.europa.eu/ docs/en-GB/document-library/Scientific-guideline/2009/10/WC500003978.pdf (last accessed in Feb. 2012)
7. European Commission Technical Guidance Document on Risk Assessment (TGD) in Support of Commission Directive 93/67/EEC, Commission Regulation (EC) No 1488/94 and Directive 98/8/EC 2003 European Chemicals Bureau Ispra, Italy URL: http://ihcp.jrc.ec.europa.eu/ (last accessed in Feb. 2012)
8. N.M. Ferguson, M.J. Keeling, W.J. Edmunds, R. Gani, B.T. Grenfell, R.M. Anderson, and S. Leach Planning for smallpox outbreaks Nature 425 2003 681 685 (Pubitemid 37314306)
9. J. Fick, R.H. Lindberg, M. Tysklind, P.D. Haemig, J. Waldenström, A. Wallensten, and B. Olsen Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus PLoS ONE 10 2007 e986
10. L. Ford Development of chronic aquatic water quality criteria and standards for silver Water Environ. Res. 73 2001 248 253 (Pubitemid 34228853)
11. G.C. Ghosh, N. Nakada, N. Yamashita, and H. Tanaka Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan Environ. Health Perspect. 118 2010 103 107
12. G.C. Ghosh, N. Nakada, N. Yamashita, and H. Tanaka Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants Chemosphere 81 2010 13 17
13. A.L. Graham, A.D. Hayward, K.A. Watt, J.G. Pilkington, J.M. Pemberton, and D.H. Nussey Fitness correlates of heritable variation in antibody responsiveness in a wild mammal Science 330 2010 662 665
14. G. He, J. Massarella, and P. Ward Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802 Clin. Pharmacokinet. 37 1999 471 484 (Pubitemid 30032251)
15. ®) under pandemic use conditions to the coastal marine compartment Environ. Int. 35 2009 931 936
16. J.D. Järhult, S. Muradrasoli, J. Wahlgren, H. Söderström, G. Orozovic, and G. Gunnarsson Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards PLoS ONE 6 2011 e24742
17. M.J. Keeling, and P. Rohani Modeling Infectious Diseases in Humans and Animals 2008 Princetion University Press New Jersey
18. J. Lienert, K. Güdel, and B.I. Escher Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes Environ. Sci. Technol. 41 2007 4471 4478 (Pubitemid 46981745)
19. H. Matsuo, H. Sakamoto, K. Arizono, and R. Shinohara Behavior of pharmaceuticals in waste water treatment plant in Japan Bull. Environ. Contam. Toxicol. 87 2011 31 35
20. H. Mestankova, K. Schirmer, B.I. Escher, U. von Gunten, and S. Canonica Removal of the antiviral agent oseltamivir and its biological activity by oxidative process Environ. Pollut. 161 2012 30 35
21. D.R.J. Moore, and P.Y. Caux Estimating low toxic effects Environ. Toxicol. Chem. 16 1997 794 801 (Pubitemid 27171907)
22. A. Moscona Global transmission of oseltamivir-resistant influenza N. Engl. J. Med. 360 2009 953 956
23. C. Prasse, M.P. Schlüsener, R. Schulz, and T. Ternes Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? Environ. Sci. Technol. 44 2010 1728 1735
24. A.C. Singer, J.D. Järhult, R. Grabic, G.A. Khan, G. Fedorova, and J. Fick Compliance to oseltamivir among two populations in Oxfordshire, United Kingdom affected by influenza A(H1N1)pdm09, November 2009 - A waste water epidemiology study PLoS ONE 8 2013 e60221
25. A.C. Singer, V. Colizza, H. Schmitt, J. Andrews, D. Balcan, and W.E. Huang Assessing the ecotoxicologic hazards of a pandemic influenza medical response Environ. Health Perspect. 119 2011 1084 1090
26. A.C. Singer, B.M. Howard, A.C. Johnson, C.J. Knowles, S. Jackman, and C. Accinelli Meeting report: risk assessment of Tamiflu use under pandemic conditions Environ. Health Perspect. 116 2008 1563 1567
27. A.C. Singer, M.A. Nunn, E.A. Gould, and A.C. Johnson Potential risks associated with the proposed widespread use of Tamiflu Environ. Health Perspect. 115 2007 102 106 (Pubitemid 46050289)
28. H. Söderström, J.D. Järhult, B. Olsen, R.H. Lindberg, H. Tanaka, and J. Fick Detection of the antiviral drug oseltamivir in aquatic environments PLoS ONE 4 2009 e6064
29. J.O. Straub An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions Ecotoxicol. Environ. Saf. 72 2009 1625 1634
30. Taiwan CDC Central Epidemic Command Center Announces Release of First 250,000 Doses of Tamiflu from National Stockpile URL: 2009 http://www.cdc.gov. tw/content.asp?cuItem=25259 (last accessed in Feb. 2012)
31. Taiwan Department of Health (Taiwan DOH) Compilation of Exposure Factors 2008 URL: http://www.bhp.doh.gov.tw/BHPnet/Portal/ (last accessed in Feb. 2012)
32. M.T. Tsai, T.C. Chern, J.H. Chuang, C.W. Hsueh, H.S. Kuo, and C.J. Liau Efficient simulation of the spatial transmission dynamics of influenza PLoS ONE 5 2010 e13292
33. US EPA Guidelines for Deriving Numerical National Water Quality Criteria for the Protection of Aquatic Organisms and Their Uses NTIS-PB85-227049 1985 Office of Water Regulations and Standards Criteria Washington, DC
34. US EPA Water Quality Criteria Documents for the Protection of Aquatic Life in Ambient Water EPA 820-B-96-001 1995 Office of Water Washington, DC
35. US EPA Technical Progress Report of the Implementation Plan for Probabilistic Ecological Assessments: Aquatic Systems. Meeting Scheduled for April 6-7 2000 United States Environmental Protection Agency Washington, DC
36. US FDA Emergency Use Authorization of Tamiflu: Fact Sheet for Health Care Providers 2009 URL: http://www.azmd.gov/Files/H1N1/tamiflu-hcp.pdf (last accessed in Feb. 2012)
37. P.J. Van der Brink, T.C.M. Brock, and L. Posthuma The value of the species-sensitivity distribution concept for predicting field effects: (Non-)confirmation using semifield experiments L. Posthuma, G.W. Suter, T.P. Traas, Species Sensitivity Distributions in Ecotoxicology 2002 Lewis Boca Raton, FL, USA 155 193
38. N. Van der Hoeven, F. Noppert, and A. Leopold How to measure no effect. Part I: towards a new measure of chronic toxicity in ecotoxicology. Introduction and workshop results Environmetrics 8 1997 241 248
39. D.J. Versteeg, S.E. Belanger, and G.J. Carr Understanding single-species and model ecosystem sensitivity: data-based comparison Environ. Toxicol. Chem. 18 1999 1329 1346 (Pubitemid 29233323)
40. Water Resources Agency, 2012. Ministry of Economic Affairs, ROC. URL: (last accessed in Feb. 2012)